South Africa’s COVID-19 vaccine rollout has been hit by further delays as it will have to discard at least 2 million Johnson & Johnson vaccines produced in the country.
The vaccines were found by the U.S Food and Drug Administration to be unsuitable for use due to possible contamination of their ingredients at a Baltimore plant.
South Africa was expecting to use them to inoculate its health care workers and people aged 60 years and older.
This is the latest setback to South Africa’s vaccine rollout which has so far given shots to just over 1% of its 60 million people.
Adolphus Mawolo reports.